What is the recommended treatment for allergic rhinitis and allergic conjunctivitis?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: August 23, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Treatment of Allergic Rhinitis and Allergic Conjunctivitis in the Emergency Department

Dual-action antihistamine/mast cell stabilizers (such as olopatadine, epinastine, ketotifen, and azelastine) are the preferred first-line therapy for allergic conjunctivitis, while second-generation oral antihistamines combined with intranasal corticosteroids are recommended as first-line treatment for allergic rhinitis. 1, 2

Initial Assessment

  • Determine if symptoms suggest allergic rhinitis:

    • Pruritus and sneezing are more common in allergic than nonallergic rhinitis
    • Seasonal exacerbations suggest allergic etiology
    • Onset typically before age 20
    • Bilateral symptoms (unilateral symptoms suggest structural problems)
  • Assess for allergic conjunctivitis symptoms:

    • Ocular itching, redness, tearing
    • Often accompanies allergic rhinitis

Treatment Algorithm for Allergic Rhinitis

First-Line Treatment:

  • Second-generation oral antihistamines (loratadine, cetirizine, fexofenadine)

    • Effective for rhinorrhea, sneezing, itching, and allergic conjunctivitis
    • Less sedating than first-generation antihistamines
    • Limited effect on nasal congestion 2
  • Intranasal corticosteroids

    • First-line for moderate-to-severe symptoms or when congestion is prominent
    • More effective than antihistamines alone 2, 3

Second-Line/Add-on Options:

  • Oral decongestants (pseudoephedrine, phenylephrine)

    • Add to antihistamines for nasal congestion
    • Monitor blood pressure in hypertensive patients
    • Avoid in patients with cardiovascular disease, glaucoma, or urinary retention 2
  • Leukotriene receptor antagonists (montelukast)

    • Similar efficacy to antihistamines
    • Particularly useful when patient has comorbid asthma
    • Can be combined with antihistamines for additive effect 2, 4
  • Combination therapy

    • Antihistamine plus intranasal corticosteroid is more effective than either agent alone
    • Short course of systemic corticosteroids (e.g., betamethasone) may be beneficial for severe acute exacerbations 5

Topical Decongestants:

  • Use only for short-term relief (≤3 days)
  • Risk of rebound congestion (rhinitis medicamentosa) with prolonged use 2

Treatment Algorithm for Allergic Conjunctivitis

First-Line Treatment:

  • Non-pharmacological approaches

    • Cold compresses
    • Irrigation with preservative-free artificial tears or saline 1
  • Dual-action antihistamine/mast cell stabilizers (topical)

    • Olopatadine, epinastine, ketotifen, azelastine
    • Provide both immediate relief and prevention
    • Superior to oral antihistamines for isolated ocular symptoms 1, 6

Second-Line Options:

  • Pure mast cell stabilizers (topical)

    • Lodoxamide, nedocromil, pemirolast, cromolyn
    • Better for prevention than acute relief
    • Most effective when used before allergen exposure 1
  • Short-term topical corticosteroids (1-2 weeks)

    • For severe symptoms unresponsive to other treatments
    • Loteprednol etabonate preferred due to reduced risk of intraocular pressure elevation
    • Avoid without ophthalmologist supervision 1

Important Cautions and Pitfalls

  • Avoid first-generation antihistamines due to sedation and anticholinergic effects 2

  • Avoid prolonged use of topical ocular vasoconstrictors as they can cause rebound hyperemia ("conjunctivitis medicamentosa") 1

  • Limit topical decongestant use to 3 days to prevent rhinitis medicamentosa 2

  • Monitor blood pressure in hypertensive patients taking oral decongestants 2

  • Avoid topical ocular corticosteroids without ophthalmologist supervision due to risks of increased intraocular pressure and cataract formation 1

Special Considerations

  • For patients with comorbid asthma:

    • Consider leukotriene receptor antagonists (montelukast)
    • Combination therapy may provide better control of both conditions 2, 4
  • For severe, refractory cases:

    • Consider referral to allergist for allergen immunotherapy evaluation
    • Allergen immunotherapy is the only disease-modifying treatment available 7
  • For contact lens wearers:

    • Remove lenses before instilling drops
    • Wait at least 5 minutes before reinsertion 1

By following this evidence-based approach, emergency department clinicians can effectively manage allergic rhinitis and allergic conjunctivitis, providing symptomatic relief while avoiding common treatment pitfalls.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.